找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Immunotherapy; Methods and Protocol Velia Siciliano,Francesca Ceroni Book 2024 The Editor(s) (if applicable) and The Author(s), unde

[復(fù)制鏈接]
樓主: 使醉
41#
發(fā)表于 2025-3-28 17:43:11 | 只看該作者
Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell Lenetically modified TILs. The protocol includes instructions for retroviral transduction and mRNA transfection of circulating T cells or T-cell lines. The GOIs most commonly introduced into the target cells are chimeric antigen receptors (CARs); genetic adjuvants, such as membrane-bound interleukins; and antitumor T-cell receptors (TCRs).
42#
發(fā)表于 2025-3-28 21:43:53 | 只看該作者
43#
發(fā)表于 2025-3-29 00:32:13 | 只看該作者
44#
發(fā)表于 2025-3-29 05:13:06 | 只看該作者
https://doi.org/10.1007/978-981-10-3193-9resent chapter, we provide a protocol to identify and characterize the time evolution of apoptosis by time-lapse fluorescence and confocal imaging in a 3D microfluidic coculture murine model including cancer and spleen cells.
45#
發(fā)表于 2025-3-29 10:39:33 | 只看該作者
46#
發(fā)表于 2025-3-29 12:39:52 | 只看該作者
47#
發(fā)表于 2025-3-29 17:19:31 | 只看該作者
https://doi.org/10.1007/978-981-10-3193-9argets for their capacity to infiltrate and eliminate human solid tumors in vivo. Here, we provide a detailed protocol to evaluate human CAR CD4. helper T cells and CD8. cytotoxic T cells in immunodeficient (NSG) mice bearing antigen-expressing human solid tumors.
48#
發(fā)表于 2025-3-29 19:56:57 | 只看該作者
https://doi.org/10.1007/978-981-10-3193-9 . transposon system via electroporation and to further expand these engineered CAR-NK cells in a large scale together with artificial antigen-presenting feeder cells. This method can stably engineer human primary NK cells with high efficiency and supply sufficient scale of engineered CAR-NK cells for the future possible clinical applications.
49#
發(fā)表于 2025-3-30 00:51:52 | 只看該作者
50#
發(fā)表于 2025-3-30 05:26:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-30 00:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
如东县| 泽普县| 崇文区| 关岭| 化州市| 兴海县| 黑水县| 永济市| 津南区| 田阳县| 九台市| 当涂县| 昆明市| 湖州市| 青海省| 西华县| 本溪| 嘉兴市| 汕头市| 乐亭县| 株洲县| 曲周县| 瑞安市| 灯塔市| 忻城县| 万荣县| 桐城市| 高淳县| 鹤壁市| 尼玛县| 大同县| 山东省| 桑植县| 襄樊市| 来宾市| 龙山县| 旌德县| 祁东县| 南宁市| 保山市| 迁西县|